Dr Pascual García Alfaro, head of the Dexeus Women’s Menopause Unit, has led a cross-sectional study that analyses whether there is an association between endogenous hormone levels and bone mineral density in postmenopausal women.
Sentinel lymph node (SLN) biopsy has recently been accepted to assess lymph node status in early-stage endometrial cancer, which is key to tailoring adjuvant treatments. However, it is unknown to what extent…
Doctors Pere Barri Soldevila, Núria Barbany and Rafael Fábregas from Dexeus Mujer, specialists in Endometriosis, Gynaecological Laparoscopy and Gynaecological Oncology, have been part of the teaching team that has offered a training course to other surgeons on vNOTES…
Dexeus Mujer has incorporated a new technique that will speed up and facilitate smear test analysis. It consists of a digital system that uses “liquid-based cytology” and involves introducing the samples in a liquid medium, which has an immediate preservative action, dissolves lumps, separates the cells…
A team of researchers from Dexeus Mujer, in collaboration with Professor FR Pérez-López of the Faculty of Medicine of the University of Zaragoza, has conducted a study to assess the relationship between endogenous hormonal factors and dominant hand grip strength in postmenopausal women.
A study conducted by Dexeus Mujer, and led by Dr Pascual García Alfaro, head of the Menopause Unit, analysed whether high homocysteine levels can cause the loss of muscle mass and handgrip strength that is characteristic of postmenopausal women.
The Sociedad Española de Fertilidad (SEF) (Spanish Fertility Society) has presented before the Senate a document agreed with seven other medical associations and representative agents in the field of fertility and reproductive health. Its aim is to open a social debate and promote political measures that contribute to tackling the alarming drop in the birth rate in Spain.
The study of fetal cardiac function at the end of first trimester has not been investigated properly, and there is a lack of reference values at early gestational weeks. For this reason, a team of researchers from Dexeus Mujer, led by Dr Pilar Prats…
A team from the Reproductive Medicine Service of Dexeus Women, led by Dr Piotr Sokol and Dr Elisabet Clua, has carried out a retrospective study with the aim of developing and validating a clinical prediction model to improve reproductive outcomes…
Dr Pascual García Alfaro, head of the Dexeus Women’s Menopause Unit, has led a cross-sectional study that analyses whether there is an association between endogenous hormone levels and bone mineral density in postmenopausal women.
A group of researchers led by Dr Mª Ángeles Rodríguez, expert in Prenatal Diagnosis at Dexeus Mujer, has conducted an observational study to determine the prevalence of anomalies of the corpus callosum (AbnCC) in a large population sample and to assess whether a systematic screening protocol for AbnCC should be established for…
At the XII ASEBIR Congress held in Palma last November, the candidacy of BARCELONA, led by Dr Montserrat Boada of Dexeus Mujer, was proclaimed as its candidate for the next ASEBIR Congress, a scientific society that brings together most…
From the 13th to the 16th of December 2023, the second edition of the Catalan Week of Simulation was held. This event, emblematic in its focus on clinical safety, is distinguished by the use of simulation as a fundamental tool for medical training and preparation.
Aromatase inhibitors (AI) have proven to be effective in women with hormone receptor-positive breast cancer (BC). However, the frequent appearance of stiffness and arthralgias following treatment with AIs results in a worsening of their quality of life and leads to consultations…
The Clínica Sant Josep (CSJ), managed by the Althaia Foundation, and the Dexeus Mujer group have signed an agreement to implement a new healthcare model at this hospital located in central Catalonia, which offers highly specialised medical care…
A multidisciplinary group of researchers at Dexeus Mujer have carried out an extensive study to evaluate the impact of adenomyosis in women undergoing IVF treatment. In total, a sample of 3503 patients undergoing their first…
DEXEUS CAMPUS
Gran Vía de Carles III 71-75
08028 Barcelona
campus@dexeus.com
(+34) 93 227 47 09
® Copyright 2021-2024 Dexeus Mujer Foundation – Gran Via Carles III 71-75. 08028 Barcelona. Spain
